Scroll down to purchase this report. If you are a Chilmark Advisory Service subscriber, please login here to access your copy.
Watch the corresponding webinar summarizing some of the report’s key findings below:
Building on the 2014 and 2016 editions of this report, Chilmark returned to the market this year to assess critical changes in vendor solutions and how well they map to provider needs. Notably, analytics solutions and care management applications are more tightly linked now and show promise for moving analytics-derived insights closer to the point of care. Analytics applications are also becoming more user-friendly — an opportunity for differentiation previously identified in the 2016 edition.
What remains the most important driver underlying the strong growth in data analytics is the move to alternative payment models, commonly referred to as value-based reimbursement (VBR). Future financial success in the VBR realm requires healthcare organizations (HCOs) to effectively manage risks, utilization, and costs while concurrently improving quality and optimizing outcomes.
This year’s report provides in-depth profiles on 17 of the leading analytics vendors in the market today. All solutions profiled have the capability to co-mingle claims and clinical data. While Chilmark noted last year that EHR vendors are well positioned to incorporate analytics into their EHR solutions, vendors of all types have promising analytics solutions both in terms of product vision and capabilities. The report also includes major changes in vendor solutions compared to those from last year’s report.
Vendors Profiled: The Advisory Board Company, Allscripts, Arcadia Healthcare Solutions, athenahealth, Inc., Caradigm, CareEvolution, Cerner Corporation, Conifer Health Solutions, eClinicalWorks, Epic Systems Corporation, Forward Health Group, Geneia LLC, Health Catalyst, HealthEC, IBM Watson Health, MCIS, Inc., Optum, Philips Wellcentive.
Number of Pages: 108., Optum, Philips Wellcentive.
Cost: $6,000
To purchase, please email john3@chilmarkresearch.com
0 Comments